The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 11, 2025 for Shree Kishoriju ....
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts more than Nifty Microcap 250 and 2.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shree Kishoriju Trading and Investments Pvt Ltd, a promoter group entity of Mangalam Drugs & Organics, has disclosed creation of a new pledge of 1,05,000 shares (0.66% of total share capital) on November 8, 2025. The pledge has been created in favour of M/s Badjate Stock Broking Pvt Ltd as security for debt. The promoter entity holds 10,98,515 shares (6.94%) in the company, of which 6,23,900 shares (3.94%) were already encumbered. After this fresh pledge, total encumbered shares stand at 7,28,900 (4.61% of share capital). The disclosure was filed under SEBI SAST Regulations, 2011 on November 11, 2025.
This is a routine promoter pledge creation to raise debt-backed funding against a small portion of holdings. With only 4.61% of shares encumbered post-event, the financial leverage risk is limited, but investors should monitor for any future invocation if the promoter faces repayment difficulties.